15 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ADVANCED PERFUSION SYSTEM 1

FDA 510(k)
FDA Class 2 ·Cardiovascular

EVONOS

FDA UDI
Gyrus ACMI, LLC·00821925018587·MINI MC GEE SMOOTH JAW FORCEPS

Plateau-C Ti

FDA UDI
Life Spine, Inc.·00190837066550·16x13 Rasp/Trial 0 deg 11mm No Stop

MSI Precision Specialty Instruments

FDA UDI
Med Saver, Inc.·00194613110239·White Nylon Tube Brushes, 6Fr, Brush Diameter 6...

MILLENNIUM

FDA UDI
Avalign Technologies, Inc.·00190776318574·Alligator Ear Forcep

FLUENCY TRACHEOBRONCHIAL STENT GRAFT

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

DC-7 DIAGNOSTIC ULTRASOUND SYSTEM

FDA 510(k)
FDA Class 2 ·Radiology

QUANTA SYSTEM S.P.A.

FDA Adverse Event
Malfunction ·QUANTA SYSTEM, S.P.A.·Product code GEX·July 10, 2015

NUVASIVE GENERAL INSTRUMENTS

FDA Adverse Event
Injury ·NUVASIVE, INC.·Product code LXH·April 12, 2024

URETEX SUPPORT PP TRANSOBTUR2 KIT X1

FDA Adverse Event
Injury ·SOFRADIM PRODUCTION·Product code FTL·May 21, 2013

ENRHYTHM DR

FDA Adverse Event
Injury ·MEDTRONIC MED REL, INC.·Product code DXY·June 16, 2011

PULSE GEN MODEL 102

FDA Adverse Event
Injury ·CYBERONICS, INC.·Product code LYJ·August 20, 2008

M2A-MAGNUM MOD HD SZ 46MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·November 4, 2022

Brand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16 Software Version: N/A Product Description: Cardiac cannula. The Edwards OptiSite Arterial Perfusion Cannluae provides or establishes arterial perfusion in the extracorporeal circuit for d 6 hours. Component: No.

FDA Enforcement
Class I ·Ongoing·Edwards Lifesciences, LLC·July 16, 2025

Ultraview SL Command Modules, Model 91496, with the Masimo SpO2 PCBA, PN: 010-1636-02. The Spacelabs Multi-parameter Module is intended for use with the Patient Care Management System (PCMS) to acquire, monitor, and process various clinical parameters from an adult or neonate/infant populations in any type of clinical environment other than home use.

FDA Enforcement
Class II ·Terminated·Spacelabs Healthcare Inc·May 13, 2015